Genomtec S.A. (GMT) — Net Asset Quality Index

Latest as of March 2026: 53.9%

Genomtec S.A. (GMT) has a Net Asset Quality Index of 53.9% as of March 2026. This metric measures the proportion of total assets financed by shareholders' equity — total assets of zł13.03 Million minus total liabilities of zł6.01 Million yields net assets of zł7.02 Million. A higher index indicates a stronger, lower-leverage balance sheet. Read Genomtec S.A. (GMT) financial obligations for a breakdown of total debt and financial obligations.

Quality Index

53.9%
Equity / Total Assets

Net Assets

zł7.02 Million
PLN

Total Assets

zł13.03 Million
PLN

Total Liabilities

zł6.01 Million
PLN

Genomtec S.A. Net Asset Quality Index Over Time (2019–2024)

This chart shows how Genomtec S.A.'s Net Asset Quality Index has evolved across 6 annual periods from 2019 to 2024. As of March 2026, the index stands at 53.9%, representing net assets of zł7.02 Million against total assets of zł13.03 Million PLN. For live market cap and overall valuation, see GMT stock market capitalisation.

Annual Net Asset Quality Index for Genomtec S.A. (2019–2024)

The table below presents the year-by-year Net Asset Quality Index for Genomtec S.A. from 2019 to 2024, covering 6 annual filings. Each row shows total assets, total liabilities, net assets, the quality index percentage, and the change in percentage points compared to the prior year. Check GMT PP&E to net assets ratio to assess the company's strategic physical and investment asset allocation.

Year Quality Index Net Assets (PLN) Total Assets Total Liabilities Change (pp)
2024 44.6% zł7.60 Million zł17.04 Million zł9.44 Million ▼ -7.4 pp
2023 52.0% zł8.30 Million zł15.97 Million zł7.67 Million ▲ +10.2 pp
2022 41.8% zł4.93 Million zł11.80 Million zł6.87 Million ▲ +24.3 pp
2021 17.5% zł738.00K zł4.22 Million zł3.48 Million ▼ -63.3 pp
2020 80.8% zł7.57 Million zł9.37 Million zł1.80 Million ▲ +42.8 pp
2019 38.0% zł1.11 Million zł2.91 Million zł1.80 Million
pp = percentage points